Background And Objectives: Donor human milk (DHM) from a human milk bank (HMB) is used to feed low-birthweight (LBW) and preterm infants when mothers cannot provide their own breastmilk. The misuse of DHM could interfere with mothers' breastmilk and weaken breastfeeding efforts. This study aimed to identify factors behind prolonged DHM usage during the first six years of Vietnam's first HMB.

Methods: Data were extracted from the Da Nang HMB's digital monitoring system. We defined prolonged DHM use as four or more days in the neonatal unit and two or more days in postnatal wards.

Results: Over six years, 25,420 infants received DHM, with 45.3% of the infants being female, 54.7% being male, 70.0% being born via cesarean section, and 77.2% being full-term. In the neonatal unit ( = 7001), 38.0% of infants used DHM for ≥4 days. Adjusted odds ratios (aORs) for prolonged use were 0.14 for infants weighing <1000 g, 0.78 for infants weighing 1000-<1500 g, and 0.67 for infants weighing ≥2000 g ( < 0.01), compared to those weighing 1500-<2000 g. Compared to gestational ages of 32-<34 weeks, the aORs were 0.26 for <28 weeks, 0.71 for 34-<37 weeks, and 0.35 for ≥37 weeks ( < 0.01). In postnatal wards ( = 18,419), 53.1% of infants used DHM for ≥2 days. Compared to term, normal-weight infants, the aORs were 1.25 for LBW-preterm, 1.17 for LBW-term, and 1.21 for normal-weight-preterm infants ( < 0.05). Prolonged DHM use was associated with cesarean births in neonatal units (aOR 2.24, < 0.01) and postnatal wards (aOR 1.44, < 0.01).

Conclusions: DHM is used briefly to bridge nutritional gaps and transition to mothers' breastmilk, but LBW, preterm births, and cesarean births are linked to prolonged use. Healthcare providers should support those at risk of prolonged DHM use and prioritize reducing unnecessary cesarean births.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11676046PMC
http://dx.doi.org/10.3390/nu16244402DOI Listing

Publication Analysis

Top Keywords

human milk
12
donor human
8
prolonged dhm
8
neonatal unit
8
dhm
6
infants
5
factors associated
4
prolonged
4
associated prolonged
4
prolonged donor
4

Similar Publications

Background: The 2019 Canada's Food Guide provides universal recommendations to individuals aged ≥2 years. However, the extent to which these recommendations are appropriate for older adults is unknown. Although ideal, conducting a large randomized controlled trial is unrealistic in the short term.

View Article and Find Full Text PDF

The prevalence of hypertension in Japan remains high, owing to the high salt content of the typical Japanese diet. Dairy-based foods may reduce blood pressure and hypertension risk. However, dairy consumption is low in Japan, and the relationships between dairy intake and blood pressure or the mechanisms by which dairy products affect blood pressure are not fully understood.

View Article and Find Full Text PDF

Review on bioproduction of sialylated human milk oligosaccharides: Synthesis methods, physiologic functions, and applications.

Carbohydr Polym

March 2025

State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu 214122, China; School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu 214122, China. Electronic address:

Human milk oligosaccharides (HMOs) are crucial for promoting neonatal health, with sialylated oligosaccharides, a significant subclass, offering a variety of health benefits such as prebiotic effects, anti-inflammatory and antimicrobial properties, antiviral defense, and cognitive development support. Among these, 3'-sialyllactose (3'-SL) and 6'-sialyllactose (6'-SL) have received "GRAS" status from the U.S.

View Article and Find Full Text PDF

Human milk oligosaccharides (HMOs) are now the principal component of the latest infant formula generation. However, it is challenging to separate and quantify highly heterogeneous isomers when analyzing HMOs. Here, we developed a high-throughput isomer-resolved quantification method for 21 native HMOs based on ultrahigh-performance liquid chromatography-mass spectrometry-multiple reaction monitoring (UPLC-MS-MRM) technology.

View Article and Find Full Text PDF

Harnessing the power of human breast milk to boost intestinal permeability for nanoparticles and macromolecules.

J Control Release

January 2025

Laboratory for Bioinspired Nano Engineering and Translational Therapeutics, Department of Chemical Engineering, Technion-Israel Institute of Technology, Haifa 3200003, Israel; Russell-Berrie Nanotechnology Institute, Technion - Israel Institute of Technology, Haifa 3200003, Israel; Cardiovascular Sciences Department, Houston Methodist Academic Institute, Houston, TX 77030, United States; Neurosurgery Department, Houston Methodist Academic Institute, Houston, TX 77030, United States; Resnick Sustainability Center of Catalysis, Technion-Israel Institute of Technology, Haifa 3200003, Israel; Bruce and Ruth Rappaport Cancer Research Center, Technion-Israel Institute of Technology, Haifa 3200003, Israel. Electronic address:

The intricate interplay between human breast milk, nanoparticles, and macromolecules holds promise for innovative nutritional delivery strategies. Compared to bovine milk and infant formula, this study explores human breast milk's role in modulating intestinal permeability and its impact on nanoparticle and macromolecule transport. Comparative analysis with bovine milk and infant formula reveals significant elevations in permeability with human breast milk, accompanied by a decrease in transepithelial electrical resistance, suggesting enhanced paracellular transport.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!